Skip to content

An Optimization Regimen of Shenqi Zengye Decoction Combined with Natrium Phosphoricum to Bowel Preparation for Colonoscopy in Elderly Patients: A Randomized Controlled Trial

An Optimization Regimen of Shenqi Zengye Decoction Combined with Natrium Phosphoricum to Bowel Preparation for Colonoscopy in Elderly Patients: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079639
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-29
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation for Colonoscopy in Elderly Patients

Interventions

Treatment group:The treatment group was given "Shenqi Zengye Decoction" combined with sodium phosphate solution. The treatment group was given 100ml of "Shenqi Zengye Decoction" orally, twice a day, 3
Control group:The control group was given placebo combined with sodium phosphate solution. The control group was given 100ml placebo orally, twice a day, 3 days before sodium phosphate intestinal prep

Sponsors

Department of Traditional Chinese Medicine and Acupuncture, The Second Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Aged 60-85 years old (inclusive) who are ready to undergo colonoscopy, both male and female; ? The patients were healthy in the past, and no other serious diseases were found after a comprehensive physical examination before enrollment; ? Patients with clear awareness, active cooperation, and able to complete intestinal preparation according to the doctor's advice; ? Join the group voluntarily and sign the informed consent, and the informed consent process complies with the relevant provisions of GCP.

Exclusion criteria

Exclusion criteria: ? Does not meet the above inclusion criteria; ? Renal insufficiency; ? A known history of allergy to the investigational agent or any of its related ingredients; ? Participate in other clinical trials within the past 1 month; ? Patients with suspected chronic or non-inflammatory diarrhea, inflammatory bowel disease, gastrointestinal bleeding, gastrointestinal obstruction, gastrointestinal stenosis, and patients with a history of abdominal surgery; ? Severe primary diseases such as ascites, diabetes, coronary heart disease, arrhythmia, heart failure, hypertension, liver, kidney, hematopoietic system, tumor and mental illness.

Design outcomes

Primary

MeasureTime frame
Boston Bowel Preparation Scale;

Secondary

MeasureTime frame
Full dose enteric preparation solution or not;Satisfaction rating;Digestive endoscope entry time;Digestive endoscope withdrawal time;

Countries

China

Contacts

Public ContactMingjun Chen

Department of Traditional Chinese Medicine and Acupuncture, The Second Medical Center, Chinese PLA General Hospital

chenmj363@yeah.net+86 185 1520 0206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026